Enliven Therapeutics (ELVN) Preferred Dividend Payments (2020)
Enliven Therapeutics' (ELVN) quarterly Preferred Dividend Payments came in at -$42000.0 in Q3 2020, down 200.0% quarter-over-quarter from $42000.0 in Q2 2020.
Enliven Therapeutics (ELVN) Preferred Dividend Payments (2020) Analysis & Trends
Enliven Therapeutics has disclosed Preferred Dividend Payments across 1 years of filings, most recently posting -$42000.0 for Q3 2020.
- Preferred Dividend Payments for Q3 2020 came in at -$42000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $7.9 million (changed N/A YoY), and the FY2021 annual result was $7.9 million, up 0.53% from the prior year.
- Preferred Dividend Payments came in at -$42000.0 for Q3 2020 at Enliven Therapeutics, down from $42000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $7.9 million in Q1 2020 to a low of -$42000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Enliven Therapeutics | 2.32 Bn | 2.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -42,000.00 |
| Jun 30, 2020 | 42,000.00 |
| Mar 31, 2020 | 7.86 Mn |